---
figid: PMC7291050__cells-09-01176-g001
figlink: pmc/articles/PMC7291050/figure/cells-09-01176-f001/
number: F1
caption: Targeting the NFAT1-MDM2-P53 pathway for cancer therapy. Different classes
  of NFAT1-MDM2 dual inhibitors can affect different components of this pathway. Lineariifolianoid
  A (LinA) and Inulanolide A (InuA) inhibit cancer cells by dual inhibition of NFAT1
  and MDM2. Japonicone A (JapA) suppresses cancer cells by binding directly to the
  p53-binding domain of MDM2 and promoting MDM2 auto-ubiquitination, and also through
  the inhibition of NFAT1-mediated MDM2 transcription and induction of NFAT1 degradation.
  MA242 induces MDM2 self-ubiquitination and represses NFAT1-mediated transcription
  of MDM2. The red minus and green symbol indicate inhibition or stimulation induced
  by NFAT-MDM2 inhibitors.
pmcid: PMC7291050
papertitle: 'Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy
  .'
reftext: Wei Wang, et al. Cells. 2020 May;9(5):1176.
pmc_ranked_result_index: '24838'
pathway_score: 0.9682122
filename: cells-09-01176-g001.jpg
figtitle: Targeting the NFAT1-MDM2-P53 pathway for cancer therapy
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7291050__cells-09-01176-g001.html
  '@type': Dataset
  description: Targeting the NFAT1-MDM2-P53 pathway for cancer therapy. Different
    classes of NFAT1-MDM2 dual inhibitors can affect different components of this
    pathway. Lineariifolianoid A (LinA) and Inulanolide A (InuA) inhibit cancer cells
    by dual inhibition of NFAT1 and MDM2. Japonicone A (JapA) suppresses cancer cells
    by binding directly to the p53-binding domain of MDM2 and promoting MDM2 auto-ubiquitination,
    and also through the inhibition of NFAT1-mediated MDM2 transcription and induction
    of NFAT1 degradation. MA242 induces MDM2 self-ubiquitination and represses NFAT1-mediated
    transcription of MDM2. The red minus and green symbol indicate inhibition or stimulation
    induced by NFAT-MDM2 inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TP53
  - MDM2
  - NFATC2
  - PPP3R2
  - PPP3CA
  - PPP3CB
  - PPP3CC
  - PPP3R1
genes:
- word: Ñ€53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: NFAT1
  symbol: NFAT1
  source: hgnc_alias_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: NFAT1
  symbol: NFAT1
  source: hgnc_alias_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: NFAT1
  symbol: NFAT1
  source: hgnc_alias_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R2
  entrez: '5535'
- word: calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CA
  entrez: '5530'
- word: calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CB
  entrez: '5532'
- word: calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CC
  entrez: '5533'
- word: calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R1
  entrez: '5534'
- word: NFAT1
  symbol: NFAT1
  source: hgnc_alias_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
chemicals: []
diseases: []
figid_alias: PMC7291050__F1
redirect_from: /figures/PMC7291050__F1
figtype: Figure
---
